Difference between revisions of "APM"
Daphne.Kothe (talk | contribs) |
Daphne.Kothe (talk | contribs) |
||
(4 intermediate revisions by the same user not shown) | |||
Line 32: | Line 32: | ||
Base Measure - 50 points (all or nothing) | Base Measure - 50 points (all or nothing) | ||
− | *Primary option: 11 measure many Stage 3 measure | + | '''*Primary option: 11 measure many Stage 3 measure''' |
− | {|class="wikitable | + | {|class="wikitable" border="1"style="margin-auto;"background:white;" |
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Measure''' | + | ! scope="col" style=" background: #ddd; colspan = '1'; border:1px solid gray;"|'''Measure''' |
! scope="col" class="unsortable" style=" background: #ddd; border:1px solid gray;"|'''Stage 2''' | ! scope="col" class="unsortable" style=" background: #ddd; border:1px solid gray;"|'''Stage 2''' | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Stage 3''' | + | ! scope="col" style=" background: #ddd; colspan = '1'; border:1px solid gray;"|'''Stage 3''' |
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Security Risk Analysis | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Security Risk Analysis |
− | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | + | ! scope="col" class="unsortable" style="text-align:left; background: green;" border:1px solid gray;"| |
− | ! scope="col" style=" background: green; border:1px solid grey;"| | + | ! scope="col" style=" background: green; colspan = '1'; border:1px solid grey;"| |
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|ePrescribing | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|ePrescribing |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Patient Access | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Access |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Patient-Specific Education | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient-Specific Education |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|View, Download or Transmit (VDT) | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|View, Download or Transmit (VDT) |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Secure Messaging | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Secure Messaging |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Patient-Generated Health Date | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient-Generated Health Date |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Patient Care Record Exchange | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Care Record Exchange |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Request/Accept Patient Care Record | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Request/Accept Patient Care Record |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Clinical Information Reconciliation | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Clinical Information Reconciliation |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|Immunization Registry Reporting | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Immunization Registry Reporting |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|(Optional) Syndromic Surveillance Reporting | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|(Optional) Syndromic Surveillance Reporting |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|(Optional) Electronic Case Reporting | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|(Optional) Electronic Case Reporting |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"|(Optional) Clinical Data Registry Reporting | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|(Optional) Clinical Data Registry Reporting |
! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: solid gray; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid gray;"| | ! scope="col" style=" background: green; border:1px solid gray;"| | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | |||
+ | <br /> | ||
+ | |||
+ | '''*Alternate Option: 16 measures all Stage 2''' | ||
+ | |||
+ | {| class="wikitable" border="1"; style="margin-auto;" background:white;" | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Measure''' | ||
+ | ! scope="col" class="unsortable" style=" background: #ddd; border:1px solid gray;"|'''Stage 2''' | ||
+ | ! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Stage 3''' | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Security Risk Analysis | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|ePrescribing | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Clinical Decision Support Ineractions (CDS) | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Drug Interaction and Drug-Allergy Checks | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Medication Orders | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Laboratory Orders | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Diagnositic Imaging Orders | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Access | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|View, Download or Transmit (VDT) | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient-Specific Education | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Secure Messaging | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Health Information Exchange | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Medication Reconciliation | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Immunization Registry | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Syndromic Surveillance | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Specialized Registry Reporting | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: solid gray; border:1px solid grey;"| | ||
+ | |- | ||
|} | |} | ||
+ | '''Performance Measure - Up to 80 points | ||
+ | * 3 Stage 3 measures - up to 10pts each | ||
− | * | + | * 5 Stage 2 measures - up to 10 pts each |
− | {| class="wikitable | + | {| class="wikitable" border="1"style="margin-auto;" background:white;" |
|- style="text-align:left;" | |- style="text-align:left;" | ||
! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Measure''' | ! scope="col" style=" background: #ddd; border:1px solid gray;"|'''Measure''' | ||
Line 121: | Line 217: | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"| | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Timely Access |
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: solid gray; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Education | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: solid gray; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|View, Download, Transmit VDT | ||
+ | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: solid gray; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Secure Messaging | ||
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: solid gray; border:1px solid grey;"| | ||
+ | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Generated Health Data | ||
+ | ! scope="col" class="unsortable" style=" background: solid grey; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"| | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Patient Care Record Exchange |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
|- style="text-align:left;" | |- style="text-align:left;" | ||
− | ! scope="col" style=" background: #ddd; border:1px solid gray;"| | + | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Request, Accept Patient Care Record |
! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ! scope="col" class="unsortable" style=" background: green; border:1px solid gray;"| | ||
! scope="col" style=" background: green; border:1px solid grey;"| | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
|- | |- | ||
+ | |- style="text-align:left;" | ||
+ | ! scope="col" style=" background: #ddd; style="text-align:left;" border:1px solid gray;"|Clinical Information Reconciliation | ||
+ | ! scope="col" class="unsortable" style=" background: solid grey; border:1px solid gray;"| | ||
+ | ! scope="col" style=" background: green; border:1px solid grey;"| | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | '''Registry bonus''' - 1 point for doin at least one extra registry extra beyond immunization | ||
+ | * Syndromic Surveillance | ||
+ | * Elecrtonic Case Reporting | ||
+ | * Public Health Registry Reporting | ||
+ | * Clinical Data Registry Reporting | ||
+ | |||
+ | '''APM Performance Categories and Weights''' | ||
+ | * Quality: 50 percent | ||
+ | * Cost: 0 percent | ||
+ | * Improvement activities: 20 percent | ||
+ | * Promoting interoperability: 30 percent | ||
+ | |||
+ | '''APM Participation Incentive''' | ||
+ | * Current incentives for APMs remain in place | ||
+ | |||
+ | * 2019-2024 - MIPS participation waived | ||
+ | 5% Medicare Part B Incentive | ||
+ | |||
+ | * 2026 and forward: MIPS participation waived | ||
+ | Higher fee schedule update |
Latest revision as of 15:11, 31 May 2018
APM - Alternative Payment Models
MACRA repealed the Sustainable Growth Rate formula and created the Quality Payment Program. The Quality Payment Program changes the way Medicare pays clinicians and streamlines multiple quality programs. There are two options to choose from based on practice size, specialty, location or patient population. These are MIPS and APM (Advanced Alternative Payment Models). In APM, incentives are earned by achieving thresholds levels of payments or patients which will exclude you from MIPS.
Advanced APMs: Eligible for 2017
- Medicare Shared Savings Program – Track 2
- Medicare Shared Savings Program – Track 3
- Next Generation ACO Model
- Comprehensive Primary Care Plus (CPC+)
- Comprehensive ESRD Care Model (Large Dialysis Organization arrangement)
- Oncology Care Model Two-Sided Risk Arrangement (started 2018)
Omissions
- Medicare Shared Savings Program – Track 1
- Comprehensive Joint Replacement
- Patient Centered Medical Homes – only count for MIPS so far
Basic Scoring Process
Base Measure - 50 points (all or nothing)
*Primary option: 11 measure many Stage 3 measure
Measure | Stage 2 | Stage 3 |
---|---|---|
Security Risk Analysis | ||
ePrescribing | ||
Patient Access | ||
Patient-Specific Education | ||
View, Download or Transmit (VDT) | ||
Secure Messaging | ||
Patient-Generated Health Date | ||
Patient Care Record Exchange | ||
Request/Accept Patient Care Record | ||
Clinical Information Reconciliation | ||
Immunization Registry Reporting | ||
(Optional) Syndromic Surveillance Reporting | ||
(Optional) Electronic Case Reporting | ||
(Optional) Clinical Data Registry Reporting |
*Alternate Option: 16 measures all Stage 2
Measure | Stage 2 | Stage 3 |
---|---|---|
Security Risk Analysis | ||
ePrescribing | ||
Clinical Decision Support Ineractions (CDS) | ||
Drug Interaction and Drug-Allergy Checks | ||
Medication Orders | ||
Laboratory Orders | ||
Diagnositic Imaging Orders | ||
Patient Access | ||
View, Download or Transmit (VDT) | ||
Patient-Specific Education | ||
Secure Messaging | ||
Health Information Exchange | ||
Medication Reconciliation | ||
Immunization Registry | ||
Syndromic Surveillance | ||
Specialized Registry Reporting |
Performance Measure - Up to 80 points
- 3 Stage 3 measures - up to 10pts each
- 5 Stage 2 measures - up to 10 pts each
Measure | Stage 2 | Stage 3 |
---|---|---|
Timely Access | ||
Patient Education | ||
View, Download, Transmit VDT | ||
Secure Messaging | ||
Patient Generated Health Data | ||
Patient Care Record Exchange | ||
Request, Accept Patient Care Record | ||
Clinical Information Reconciliation |
Registry bonus - 1 point for doin at least one extra registry extra beyond immunization
- Syndromic Surveillance
- Elecrtonic Case Reporting
- Public Health Registry Reporting
- Clinical Data Registry Reporting
APM Performance Categories and Weights
- Quality: 50 percent
- Cost: 0 percent
- Improvement activities: 20 percent
- Promoting interoperability: 30 percent
APM Participation Incentive
- Current incentives for APMs remain in place
- 2019-2024 - MIPS participation waived
5% Medicare Part B Incentive
- 2026 and forward: MIPS participation waived
Higher fee schedule update